TY - DATA T1 - Supplementary Material for: Physiological and Molecular Effects of in vivo and ex vivo Mild Skin Barrier Disruption PY - 2018/03/06 AU - Pfannes E.K.B. AU - Weiss L. AU - Hadam S. AU - Gonnet J. AU - Combardière B. AU - Blume-Peytavi U. AU - Vogt A. UR - https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Physiological_and_Molecular_Effects_of_in_vivo_and_ex_vivo_Mild_Skin_Barrier_Disruption/5951797 DO - 10.6084/m9.figshare.5951797.v1 L4 - https://ndownloader.figshare.com/files/10659643 L4 - https://ndownloader.figshare.com/files/10659646 L4 - https://ndownloader.figshare.com/files/10659649 L4 - https://ndownloader.figshare.com/files/10659652 L4 - https://ndownloader.figshare.com/files/10659655 KW - Skin barrier KW - Cyanoacrylate skin surface stripping KW - Transcutaneous vaccination KW - Particle penetration KW - Tape stripping N2 - The success of topically applied treatments on skin relies on the efficacy of skin penetration. In order to increase particle or product penetration, mild skin barrier disruption methods can be used. We previously described cyanoacrylate skin surface stripping as an efficient method to open hair follicles, enhance particle penetration, and activate Langerhans cells. We conducted ex vivo and in vivo measurements on human skin to characterize the biological effect and quantify barrier disruption-related inflammation on a molecular level. Despite the known immunostimulatory effects, this barrier disruption and hair follicle opening method was well accepted and did not result in lasting changes of skin physiological parameters, cytokine production, or clinical side effects. Only in ex vivo human skin did we find a discrete increase in IP-10, TGF-β, IL-8, and GM-CSF mRNA. The data underline the safety profile of this method and demonstrate that the procedure per se does not cause substantial inflammation or skin damage, which is also of interest when applied to non-invasive sampling of biomarkers in clinical trials. ER -